MalignancyMalignancy () is the tendency of a medical condition to become progressively worse; the term is most familiar as a characterization of cancer. A malignant tumor contrasts with a non-cancerous benign tumor in that a malignancy is not self-limited in its growth, is capable of invading into adjacent tissues, and may be capable of spreading to distant tissues. A benign tumor has none of those properties, but may be harmful to health. The term benign in more general medical use characterises a condition or growth that is not cancerous, i.
P16Le p16 est une protéine suppresseuse de tumeur également connue sous le nom d'inhibiteur de kinase cycline-dépendante 2A (CDKN2A). Elle est un inhibiteur du complexe CDK4/CDK6-Cycline D. Ce complexe phosphoryle pRB (protéine du rétinoblastome), ce qui a pour conséquence de l'empêcher de se lier au facteur de transcription E2F. Celui-ci peut alors activer la transcription de nombreux gènes favorisant le passage de la cellule de la phase G1 à la phase S.
Pre-replication complexA pre-replication complex (pre-RC) is a protein complex that forms at the origin of replication during the initiation step of DNA replication. Formation of the pre-RC is required for DNA replication to occur. Complete and faithful replication of the genome ensures that each daughter cell will carry the same genetic information as the parent cell. Accordingly, formation of the pre-RC is a very important part of the cell cycle. As organisms evolved and became increasingly more complex, so did their pre-RCs.
Pap testThe Papanicolaou test (abbreviated as Pap test, also known as Pap smear (AE), cervical smear (BE), cervical screening (BE), or smear test (BE)) is a method of cervical screening used to detect potentially precancerous and cancerous processes in the cervix (opening of the uterus or womb) or colon (in both men and women). Abnormal findings are often followed up by more sensitive diagnostic procedures and, if warranted, interventions that aim to prevent progression to cervical cancer.
